83 related articles for article (PubMed ID: 38653565)
41. Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes.
Kristinsson SY; Björkholm M; Hultcrantz M; Derolf ÅR; Landgren O; Goldin LR
J Clin Oncol; 2011 Jul; 29(21):2897-903. PubMed ID: 21690473
[TBL] [Abstract][Full Text] [Related]
42. Systemic and immune manifestations in myelodysplasia: a multicenter retrospective study.
de Hollanda A; Beucher A; Henrion D; Ghali A; Lavigne C; Lévesque H; Hamidou M; Subra JF; Ifrah N; Belizna C
Arthritis Care Res (Hoboken); 2011 Aug; 63(8):1188-94. PubMed ID: 21584947
[TBL] [Abstract][Full Text] [Related]
43. Gastrointestinal manifestations of Behçet's disease.
Ebert EC
Dig Dis Sci; 2009 Feb; 54(2):201-7. PubMed ID: 18594975
[TBL] [Abstract][Full Text] [Related]
44. Behcet's disease associated with bone marrow failure in Korean patients: clinical characteristics and the association of intestinal ulceration and trisomy 8.
Ahn JK; Cha HS; Koh EM; Kim SH; Kim YG; Lee CK; Yoo B
Rheumatology (Oxford); 2008 Aug; 47(8):1228-30. PubMed ID: 18550640
[TBL] [Abstract][Full Text] [Related]
45. Cytogenetic features in myelodysplastic syndromes.
Haase D
Ann Hematol; 2008 Jul; 87(7):515-26. PubMed ID: 18414863
[TBL] [Abstract][Full Text] [Related]
46. Successful treatment of myelodysplastic syndrome (MDS)-related intestinal Behçet's disease by up-front cord blood transplantation.
Nonami A; Takenaka K; Sumida C; Aizawa K; Kamezaki K; Miyamoto T; Harada N; Nagafuji K; Teshima T; Harada M
Intern Med; 2007; 46(20):1753-6. PubMed ID: 17938534
[TBL] [Abstract][Full Text] [Related]
47. Development of consensus statements for the diagnosis and management of intestinal Behçet's disease using a modified Delphi approach.
Kobayashi K; Ueno F; Bito S; Iwao Y; Fukushima T; Hiwatashi N; Igarashi M; Iizuka BE; Matsuda T; Matsui T; Matsumoto T; Sugita A; Takeno M; Hibi T
J Gastroenterol; 2007 Sep; 42(9):737-45. PubMed ID: 17876543
[TBL] [Abstract][Full Text] [Related]
48. Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: significance of trisomy 8.
Kawabata H; Sawaki T; Kawanami T; Shimoyama K; Karasawa H; Fukushima T; Masaki Y; Ogawa N; Hirose Y; Ozaki K; Shimanaka K; Takase S; Ueno H; Umehara H
Intern Med; 2006; 45(22):1309-14. PubMed ID: 17170506
[TBL] [Abstract][Full Text] [Related]
49. Incidence and prognostic significance of karyotype abnormalities in de novo primary myelodysplastic syndromes: a study on 331 patients from a single institution.
Bernasconi P; Klersy C; Boni M; Cavigliano PM; Calatroni S; Giardini I; Rocca B; Zappatore R; Caresana M; Quarna J; Lazzarino M; Bernasconi C
Leukemia; 2005 Aug; 19(8):1424-31. PubMed ID: 15920496
[TBL] [Abstract][Full Text] [Related]
50. Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes.
Campioni D; Secchiero P; Corallini F; Melloni E; Capitani S; Lanza F; Zauli G
Am J Pathol; 2005 Feb; 166(2):557-63. PubMed ID: 15681838
[TBL] [Abstract][Full Text] [Related]
51. Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities.
Chen G; Zeng W; Miyazato A; Billings E; Maciejewski JP; Kajigaya S; Sloand EM; Young NS
Blood; 2004 Dec; 104(13):4210-8. PubMed ID: 15315976
[TBL] [Abstract][Full Text] [Related]
52. Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study.
Giannouli S; Voulgarelis M; Zintzaras E; Tzioufas AG; Moutsopoulos HM
Rheumatology (Oxford); 2004 May; 43(5):626-32. PubMed ID: 14983106
[TBL] [Abstract][Full Text] [Related]
53. Autologous hematopoietic stem cell transplantation for severe/refractory intestinal Behcet disease.
Rossi G; Moretta A; Locatelli F
Blood; 2004 Jan; 103(2):748-50. PubMed ID: 14702292
[No Abstract] [Full Text] [Related]
54. Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet's disease.
Düzgün N; Ayaşlioğlu E; Tutkak H; Aydintuğ OT
Rheumatol Int; 2005 Jan; 25(1):1-5. PubMed ID: 14600787
[TBL] [Abstract][Full Text] [Related]
55. Target organ associations in Turkish patients with Behçet's disease: a cross sectional study by exploratory factor analysis.
Tunc R; Keyman E; Melikoglu M; Fresko I; Yazici H
J Rheumatol; 2002 Nov; 29(11):2393-6. PubMed ID: 12415598
[TBL] [Abstract][Full Text] [Related]
56. Behçet's disease.
Sakane T; Takeno M; Suzuki N; Inaba G
N Engl J Med; 1999 Oct; 341(17):1284-91. PubMed ID: 10528040
[No Abstract] [Full Text] [Related]
57. Behçet's Disease.
Kaklamani VG; Vaiopoulos G; Kaklamanis PG
Semin Arthritis Rheum; 1998 Feb; 27(4):197-217. PubMed ID: 9514126
[TBL] [Abstract][Full Text] [Related]
58. Behçet's disease associated with myelodysplastic syndromes. A case report and a review of the literature.
Ohno E; Ohtsuka E; Watanabe K; Kohno T; Takeoka K; Saburi Y; Kikuchi H; Nasu M
Cancer; 1997 Jan; 79(2):262-8. PubMed ID: 9010099
[TBL] [Abstract][Full Text] [Related]
59. Behçet disease (Behçet syndrome).
Shimizu T; Ehrlich GE; Inaba G; Hayashi K
Semin Arthritis Rheum; 1979 May; 8(4):223-60. PubMed ID: 382361
[No Abstract] [Full Text] [Related]
60. Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study.
Park JB; Han SJ; Lee SB; Kim DH; Cheon JH; Hwang SW; Ye BD; Yang SK; Park SJ; Park SH;
Yonsei Med J; 2024 May; 65(5):265-275. PubMed ID: 38653565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
